isopentenyl pyrophosphate has been researched along with bromohydrin pyrophosphate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gossman, W; Oldfield, E | 1 |
| Eberl, M; Engel, R; Haug, C; Hintz, M; Jomaa, H; Kletschek, Y; Kuhl, T; Moll, J; Ostrovsky, DN; Reichenberg, A | 1 |
| Belmant, C; Boëdec, A; Dessolin, J; Herbette, G; Ingoure, S; Kraus, JL; Raymond, C; Sicard, H | 1 |
| Espinosa, E; Fournié, JJ; Hudrisier, D; Tabiasco, J | 1 |
| Casetti, R; Colizzi, V; D'Offizi, G; Dieli, F; Malkovsky, M; Mattei, M; Perretta, G; Poccia, F; Taglioni, A | 1 |
| Boudjema, K; Bouet-Toussaint, F; Cabillic, F; Catros, V; Daniel, P; de La Pintière, CT; Lavoué, V; Mönkkönen, H; Mönkkönen, J; Rioux-Leclerc, N; Toutirais, O; Turlin, B | 1 |
6 other study(ies) available for isopentenyl pyrophosphate and bromohydrin pyrophosphate
| Article | Year |
|---|---|
Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.
Topics: Antigens, Bacterial; Lymphocyte Activation; Models, Molecular; Phosphoproteins; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes | 2002 |
Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
Topics: Binding, Competitive; Diphosphates; Humans; In Vitro Techniques; Indicators and Reagents; Magnetic Resonance Spectroscopy; Molecular Weight; Structure-Activity Relationship; T-Lymphocytes | 2003 |
Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate.
Topics: Animals; Diphosphates; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Macaca fascicularis; Magnetic Resonance Spectroscopy; Male; Models, Animal; Molecular Structure; Organophosphates; Organophosphorus Compounds; Rats; Stereoisomerism; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2008 |
Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens.
Topics: Antigens; Burkitt Lymphoma; Cell Communication; Cell Membrane; Diphosphates; Hemiterpenes; Humans; K562 Cells; Levamisole; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; Solubility; T-Lymphocyte Subsets; Tumor Cells, Cultured | 2002 |
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.
Topics: 2,3-Diphosphoglycerate; Animals; Antigens; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphates; Diphosphonates; Epoxy Compounds; Hemiterpenes; Immunologic Memory; Injections, Intravenous; Injections, Subcutaneous; Interferon-gamma; Interleukin-2; Macaca fascicularis; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Th1 Cells | 2005 |
Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
Topics: Adenocarcinoma; Aged; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Coculture Techniques; Colorectal Neoplasms; Cytotoxicity, Immunologic; Dendritic Cells; Diphosphates; Diphosphonates; Female; Flow Cytometry; Hemiterpenes; Humans; Imidazoles; Immunotherapy, Adoptive; Liver Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Zoledronic Acid | 2010 |